Global Carrier Screening Market Research Report

1. Global Carrier Screening Market Size – Forecasts to 2026 The results analyzed by GME showed that the Global Carrier Screening Market will grow with a CAGR value of 17.1 percent, to hit xx billion USD by 2026. Carrier screening is a genetic test used to determine if a healthy individual is a carrier of any recessive gene or genetic disorder. It offers life-long data about the reproductive risk of a person and the likelihood of having a child with a genetic disorder. The development is expected to be driven by a rising occurrence of chromosomal anomalies and an increasing demand for carrier screening during the forecast timeline. Browse 157 Market Data Tables and 117 Figures spread through 189 Pages and in-depth TOC on "Carrier Screening Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-carrier-screening-market-2599 By Type (Targeted Disease Carrier Screening, Expanded Carrier Screening), By Medical Condition (Neurological Conditions, Pulmonary Conditions, Hematological Conditions, Other Medical Conditions), By Technology (Microarrays, DNA Sequencing, Polymerase Chain Reaction), By End-User (Reference Laboratories, Hospitals, Physician Offices, and Clinics, Others), By Product & Service (Services, Products), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End- User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights The rising incidence of chromosomal anomalies across developed and developing regions will drive the market over the forecasted timeline The increasing number of accredited laboratories will help the market grow tremendously from 2021 to 2026 As of 2020, hospitals based on the end-user will expand the fastest with the highest value of CAGR. Fulgent Genetics Inc, Sema4, Illumina Inc., Luminex Corporation, Laboratory Corporation of America Holdings, Gene By Gene, Invitae Corporation, Optogenetics Corporation, Asuragen, Pathway Genomics, Eurofins Scientific, Opko Health, Quest Diagnostics Incorporated, Myriad Genetics, Thermo Fisher Scientific Inc, Natera Inc, BGI, Progenity, Centogene, True Health are the major players competing in this market.

2. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-carrier-screening- market-2599 Type Outlook (Revenue, USD Billion, 2021-2026) Targeted Disease Carrier Screening Expanded Carrier Screening Medical Condition Outlook (Revenue, USD Billion, 2021-2026) Neurological Conditions Pulmonary Conditions Hematological Conditions Other Medical Conditions Technology Outlook (Revenue, USD Billion, 2021-2026) Microarrays DNA Sequencing Polymerase Chain Reaction Product & Service Outlook (Revenue, USD Billion, 2021-2026) Services Products End-User Outlook (Revenue, USD Billion, 2021-2026) Reference Laboratories Hospitals, Physician Offices  Clinics Others Regional Outlook (Revenue, USD Billion, 2021-2026) North America The U.S. Canada Mexico

3. Europe Germany UK France Spain Italy Rest of Europe Asia Pacific China India Japan South Korea Australia Rest of APAC Central & South America Brazil Argentina Rest of CSA Middle East & Africa Saudi Arabia UAE Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php